CS Paper Radar

A Structural FHMM for Interpretable Disease Trajectories in T2DM

Alessandro Mari, Ekaterina Krymova, Guillaume Obozinski, Maria Luisa Marques de Sa Faquetti, Adrian Martinez de la Torre, Andrea Burden

cs.LG ·submitted 2026-08-25 09:51 UTC · v1

Abstract

In this work, we propose a structural variant of the Factorial Hidden Markov Model (FHMM) for the analysis of disease trajectories in patients with Type 2 diabetes mellitus (T2DM). The model represents a patient's latent health state as a combination of multiple independent, simultaneously evolving components, associated with comorbidities and lab results. This structured latent representation facilitates the identification of clinically meaningful patient states and clustering of common disease trajectories. We evaluate the proposed approach using The IQVIA Medical Research Data incorporating data from THIN, a Cegedim database of anonymized electronic health records (EHR), identifying patients with a first-ever prescription for a non-insulin antidiabetic drug (NIAD) between January 2006 and December 2019. The model identifies multiple clinically coherent latent components corresponding to known patterns of diabetes-related complications and reveals heterogeneous progression pathways, including distinct microvascular-dominant and multi-organ trajectories associated with elevated comorbidity burden and mortality. These results demonstrate that the proposed framework captures meaningful longitudinal structure in EHR data and provides interpretable insights into the evolution of T2DM and its comorbidities.

Closest papers

Nearest neighbours by meaning across the whole index.

DIASENTINEL: An Auditable Multi-Agent System for Guideline-Grounded Diabetes Risk Screening

cs.CL ·2026-08-31 ·Yung Wei Shueh, Zhi-Jie Chen, Chia-Hsuan Hsu, Hsin-Ling Hsu, Donghua Zhang +7 more
top venue similarity 0.62
Abstract

Large language models (LLMs) offer promising clinical decision support but remain vulnerable to hallucinated facts, unsupported recommendations, and citation errors. We present DIASENTINEL, a fully on-premise multi-agent system for one-year type 2 diabetes mellitus (T2DM) risk screening and guideline-grounded report generation from electronic health records (EHRs). The system integrates calibrated risk prediction, deterministic clinical signal extraction, Reciprocal Rank Fusion over American Diabetes Association (ADA) guidelines, and a hybrid verification layer combining rule-based checks with LLM entailment. The demonstration provides a real-time batch-screening dashboard and an interactive patient report interface with cited recommendations, verification results, and raw EHR comparison. DIASENTINEL demonstrates a practical framework for reliable, auditable, and privacy-preserving LLM-based clinical decision support.

0.33

Glyph: An Interpretability Engine for AI-Driven Scientific Discovery in Clinical Data

cs.AI ·2026-11-06 ·Robbie Holland, Ashwin Kumar, Mateus A. Esmeraldo, David Le, Andrea Fisher +17 more
code/data similarity 0.61
Abstract

Automated scientific discovery has the potential to advance understanding of disease mechanisms and accelerate identification of early disease markers. Manual data annotation is infeasible at population scale, motivating methods that automatically extract pre-defined phenotypes in multimodal and unstructured clinical data. Such pre-defined feature sets determine and limit which associations these approaches can discover. This limitation extends to agentic AI systems that use these tools to query population-scale data. In contrast, foundation models (FMs) trained on large volumes of clinical data can perform tasks beyond their training objectives. This suggests their latent embeddings may represent novel or unexplored features that could yield insights into disease mechanisms, yet such latent features remain difficult to interpret. To address this challenge, we introduce Glyph, an automated multistage framework that extracts features from multimodal and unstructured clinical data using FMs and sparse autoencoders, interprets them as coded clinical concepts, and evaluates their value for clinical scientific discovery. We applied Glyph to abdominal CT volumes, CT radiology reports and laboratory measurements from 41,628 patients across different institutions. We identified 397 predictive concepts supported by 4,463 Bonferroni-significant associations. Moreover, a majority of discovered associations were automatically reproducible in held-out cohorts across different sites. Glyph concepts provided complementary associations to literature-derived markers, leading to gains in predictive power. We envision that interpretability can extend beyond a mechanistic understanding of neural networks to connecting implicitly learned features with clinical knowledge and establishing their significance for patient outcomes. We release Glyph at https://github.com/StanfordMIMI/Glyph.

0.40

DeMMO: Longitudinal and Cross-Disease Modelling of Digital Mobility Outcomes via Multi-Task Learning

cs.LG cs.AI ·2026-08-25 ·Menghui Zhou, Zhipeng Yuan, Vitaveska Lanfranchi, Po Yang
positioncode/data similarity 0.58
Abstract · 24 pages, 5 figures, and 8 tables. Implementation code and experimental results are available at https://github.com/menghui-zhou/DeMMO

Digital mobility outcomes (DMOs) derived from wearable sensors characterise mobility in daily life and offer a promising means of monitoring disease progression. However, existing DMO studies have typically focused on either a single disease or a single visit. To the best of our knowledge, we are the first to define and study the practical problem of cross-disease longitudinal DMO modelling. We argue that this problem should satisfy at least two requirements. First, the temporal progression of DMOs should be modelled within each disease, as mobility-limiting diseases evolve over time. Second, multiple mobility-limiting diseases should be modelled jointly, as different diseases affect different aspects of human mobility. To address this problem, we propose DeMMO, an interpretable framework for longitudinal, multi-disease, and multi-outcome learning. Its central technical contribution is an interpretable cross-disease and cross-outcome relation-learning mechanism that infers signed relations directly from learned longitudinal DMO-outcome mappings, thereby enabling selective information sharing across cohorts without requiring paired participants. We evaluate DeMMO on the recently released, large-scale, multicentre Mobilise-D dataset, which presents a challenging modelling setting involving longitudinal observations, multiple clinical outcomes, and four participant-disjoint cohorts representing distinct mobility-limiting diseases. Compared with eight strong structural longitudinal and deep-regression baselines, DeMMO achieves the best overall predictive performance and outperforms the baselines for most individual outcomes. Stability selection further identifies reliable longitudinal DMO patterns that can inform subsequent clinical validation and disease monitoring. The implementation code is available at https://github.com/menghui-zhou/DeMMO.

0.34

HealthLoopQA: A Context-Aware Question Answering Benchmark for Interpreting Wearable Monitoring Data in Diabetes Care

cs.LG ·2026-09-07 ·Yuchen Niu, Yanan Ma, Srinivasan Nandakumar, Maolin Chen, Viktor Schlegel +5 more
benchmark similarity 0.58
Abstract

As medical wearables become integrated into daily chronic disease care, effectively interpreting longitudinal monitoring data is essential for patients and clinicians to understand health trends, detect safety-critical events, and make informed decisions. While large language models (LLMs) show promise for transforming this streaming physiological data into personalized health insights, evaluating their reasoning capability and analytical rigor in diverse monitoring tasks remains a fundamental challenge. Existing medical wearable question answering (QA) benchmarks primarily assess short-horizon classification or statistical summaries, largely ignoring the long-term patterns, therapeutic and behavioural contexts, and potential system failures inherent in real-world deployments. To address this, we introduce HealthLoopQA, a comprehensive diagnostic benchmark for evaluating LLM reasoning over continuous diabetes monitoring data. Grounded in a novel taxonomy of eleven atomic reasoning abilities, HealthLoopQA comprises 127 tasks and over 1,500 QA instances spanning process mining, anomaly detection, and prediction over 30-day horizons. To systematically evaluate safety awareness, we complement real-world datasets with a fault-injected simulation testbed modeling diverse device malfunctions and cyber-physical attacks to generate physiologically plausible hazard scenarios. Evaluating state-of-the-art LLMs across prompting and agentic frameworks reveals severe limitations in complex temporal pattern mining. Furthermore, we identify a broader phenomenon of In-context Laziness under long-context prompting, highlighting critical open challenges in deploying LLMs for rigorous long-horizon medical reasoning.

0.37

LifeLong Digital Twin: A Unified Modeling Paradigm and Agent Harness for Event-Driven Lifelong Health State Trajectories

cs.AI q-bio.QM ·2026-10-04 ·Jin Jiang, Sean Yates, Jasper Chong, Raymond Brooks, Alex Lawson +2 more
similarity 0.58
Abstract · 15 pages, 5 figures, 2 tables. Technical report

Human health is a continuous, dynamic trajectory shaped by the cumulative interplay of biological processes, clinical events, behaviors and environmental exposures across the life course. Unifying the full breadth of lifelong health information, including longitudinal records, genetic variation, molecular profiles and environmental histories, is essential for whole-person modeling and remains a major challenge. We introduce LifeLong Digital Twin, a unified, event-driven modeling paradigm that organizes Life Events into daily Health States and accumulates them into Lifelong Health Context. An accompanying Agent Harness incorporates multimodal evidence beyond the language model's textual context. We evaluate four language models across 25 disease endpoints on three tasks: Disease Trajectory Forecasting, Disease Risk Ranking and Multi-horizon Disease Prediction. The approach yields marked gains over the reference condition: model-averaged F1 increases by 22.0% for disease identification in trajectory forecasting and 18.3% for five-year disease outcomes; thyroid-disease F1 reaches 0.669. The framework provides a foundation for whole-person digital twins and research on personalized lifelong disease prevention.

0.20

A Neurosymbolic Multimodal Framework for 30-Day Diabetic Readmission Prediction: Integrating Structured EHR Data, Dense Clinical Embeddings, and Knowledge-Grounded Symbolic Extraction

cs.AI ·2026-11-18 ·Una Suman Kumar Patro, Sibangi Subhadarsani, Narendra Badam
benchmark similarity 0.58
Abstract

Unplanned 30-day readmissions among patients with diabetes mellitus impose a substantial clinical and economic burden, yet most predictive models use only structured electronic health record (EHR) data and ignore free-text clinical notes, which often contain code-mixed Hindi-English (Hinglish) phrasing and negation that general-purpose language models parse unreliably. We propose a neurosymbolic multimodal framework evaluated on the public Diabetes 130-US Hospitals dataset (101,766 encounters; 71,518 patients) with a patient-level grouped 80/20 split. Three streams are fused: engineered structured features; 32 components of Bio_ClinicalBERT note embeddings obtained by truncated singular value decomposition; and symbolic entities extracted by an open-weight clinical language model within a three-stage hybrid retrieval-augmented generation pipeline (dense retrieval, sparse lexical retrieval, and cross-encoder re-ranking) with reflective negation auditing. A cost-sensitive XGBoost classifier with a decision threshold calibrated by Youden's J statistic produces the prediction. On the held-out test cohort (n = 20,153), the structured baseline achieved an area under the receiver operating characteristic curve (AUROC) of 0.6477, sensitivity of 0.5839, and Brier score of 0.1080. The full multimodal model achieved the highest sensitivity (0.6667; +8.28 percentage points), the best F2-score (0.3824), and the lowest Brier score (0.0977), at a slightly lower AUROC (0.6375) and specificity (0.5161). Shapley additive explanations showed that prior utilization dominates risk, with compressed narrative components among the top predictors. On a 500-note code-switched benchmark, grounded retrieval raised Hinglish symptom recall from 4.8% to 40.2% and precision from 3.1% to 45.2%, while reducing entity hallucinations from 1.74 to 0.00 per note.

0.12

TRACER, a time-to-event EHR foundation model for disease detection across health systems

cs.CE cs.LG ·2026-10-29 ·Mara Pleasure, Ekaterina Redekop, Vedrana Ivezic, Rushikesh Kulkarni, Aaron Chin +2 more
similarity 0.57
Abstract

Foundation models trained on longitudinal electronic health records (EHRs) can predict clinical diagnoses years in the future, making them a potential tool for disease screening. We developed TRACER (Temporal Risk Assessment with Clinical EHR Representations), a decoder-based foundation model pretrained on data from over 4.5 million patients from four health systems, and evaluated it on 16 incident diseases at 1-, 2-, and 5-year horizons in more than 2 million patients from two health systems excluded from model development. In contrast to typical evaluations that focus on global metrics (e.g., AUROC), we measured performance at the low false-positive rates that are realistic for screening. We found that TRACER retained its discrimination in external health systems, and at 95% specificity, the patients it flagged were up to eight times more likely to be diagnosed within a year than unselected patients. Evaluating at this operating point also revealed what global metrics alone did not: detection and false-alert burden varied across diseases and health systems, even when discrimination appeared stable. Our results illustrate the potential of foundation models for screening and underscore the need for evaluation in health systems excluded from development to assess disease detection and false-alert burden at levels appropriate for intended clinical use.}

0.16

A Two-Level Clinical Novelty Prioritization Framework for Disease Trajectories Discovered from Longitudinal Electronic Health Records

cs.LG ·2026-10-14 ·Jin-Jia Zheng, Vincent S. Tseng
similarity 0.57
Abstract

Graph-based analysis of electronic health records (EHRs) yields disease-trajectory catalogs, but structural support does not establish semantic novelty. We present a two-level framework to prioritize 99,527 branching motifs previously discovered by an upstream patient-disjoint, train-only MIMIC-IV v3.1 pipeline and frozen after validation-based catalog selection. The framework separates path-level and node-to-endpoint semantic sparsity from reliability-adjusted clinical priority. Three deterministic textualizations per motif or node-target pair were embedded with BAAI/bge-small-en-v1.5 and calibrated against 166,972 pre-2023 PubMed references using mean top-20 cosine distance. Positive recombination occurred in 8.63% of motifs and had negligible effect on global ranking, whereas specificity and support/GNN reliability terms changed clinical-priority ordering. Robustness analyses across neighbor counts, templates, encoders, generic-label taxonomies, score settings, PrimeKG, and corrected density-based RND showed that broad ordering was more stable than hard top-k membership. A semantic-dose analysis did not support a monotonic relation between score and forecasting benefit after endpoint and token-count adjustment (1.96 days per SD; 95% CI, -0.75 to 4.68). In the frozen catalog-q90 high-semantic subgroup, branch-enhanced forecasting reduced conditional event-time MAE by 20.1 days (95% CI, 13.3-27.0) and sMAPE by 2.37 percentage points (95% CI, 1.81-2.93), while discrimination and endpoint-ranking differences were inconclusive. Corrected RND showed low tail agreement with the primary score (Spearman rho = 0.430; q90 Jaccard = 0.125) despite a similar aggregate timing association. These findings support representation-aware, uncertainty-aware literature-relative prioritization of discovered trajectories rather than causal discovery or clinician-adjudicated novelty.

0.31